Hideyuki Takahashi1, Koichi Sakakura1, Hiroe Tada1, Kyoichi Kaira2, Tetsunari Oyama3, Kazuaki Chikamatsu1. 1. Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan. 2. Department of Oncology Clinical Development, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan. 3. Department of Pathology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Abstract
BACKGROUND: Several inflammatory biomarkers are considered potential prognostic factors in various cancers. This study aimed to investigate the prognostic significance and population dynamics of pretreatment inflammatory biomarker levels in patients with oropharyngeal squamous cell carcinoma (OPSCC). METHODS: The influence of neutrophil counts, lymphocyte counts, monocyte counts, platelet counts, lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on progression-free survival (PFS), and overall survival (OS) was analyzed. We also analyzed the peripheral blood mononuclear cells collected from patients and healthy donors (HDs). RESULTS: Elevated monocyte count was an independent prognostic factor for PFS. Low LMR was an independent prognostic factor for OS. The proportion of intermediate monocytes was lower, and that of classical monocytes was higher in patients than in HDs. Furthermore, PD-L1 expression on monocytes was higher in patients than in HDs. CONCLUSIONS: We showed the prognostic significance and population dynamics of peripheral monocytes in patients with OPSCC.
BACKGROUND: Several inflammatory biomarkers are considered potential prognostic factors in various cancers. This study aimed to investigate the prognostic significance and population dynamics of pretreatment inflammatory biomarker levels in patients with oropharyngeal squamous cell carcinoma (OPSCC). METHODS: The influence of neutrophil counts, lymphocyte counts, monocyte counts, platelet counts, lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on progression-free survival (PFS), and overall survival (OS) was analyzed. We also analyzed the peripheral blood mononuclear cells collected from patients and healthy donors (HDs). RESULTS: Elevated monocyte count was an independent prognostic factor for PFS. Low LMR was an independent prognostic factor for OS. The proportion of intermediate monocytes was lower, and that of classical monocytes was higher in patients than in HDs. Furthermore, PD-L1 expression on monocytes was higher in patients than in HDs. CONCLUSIONS: We showed the prognostic significance and population dynamics of peripheral monocytes in patients with OPSCC.
Authors: Shu Wen; Nan Chen; Ying Hu; Litao Huang; Jin Peng; Meina Yang; Xiaoyang Shen; Yang Song; Liangzhi Xu Journal: Cancer Med Date: 2021-02-16 Impact factor: 4.452
Authors: Marta Ruiz-Ranz; Paloma Lequerica-Fernández; Tania Rodríguez-Santamarta; Faustino J Suárez-Sánchez; Rosa M López-Pintor; Juana M García-Pedrero; Juan C de Vicente Journal: Front Immunol Date: 2022-07-26 Impact factor: 8.786
Authors: Yago Pico de Coaña; Maria Wolodarski; Irene van der Haar Àvila; Takahiro Nakajima; Stamatina Rentouli; Andreas Lundqvist; Giuseppe Masucci; Johan Hansson; Rolf Kiessling Journal: Oncoimmunology Date: 2020-08-28 Impact factor: 8.110